VIR FY 2020 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$67M+9357.8% YoY

Gross Profit

$67M100.0% margin

Operating Income

-$297M-441.6% margin

Net Income

-$299M-444.1% margin

EPS (Diluted)

$-2.51

Cash Flow

Operating Cash Flow

-$191M

Free Cash Flow

-$197M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$919M

Total Liabilities

$202M

Stockholders' Equity

$717M

Cash & Equivalents

$437M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$711,000	+9357.8%
Gross Profit	$67M	$711,000	+9357.8%
Operating Income	-$297M	-$178M	-66.9%
Net Income	-$299M	-$175M	-71.0%